by University of AberdeenRelationship between steady-state plasma levels of hydromethylthionine and decline on the ADAS-Cog11scale over 65 weeks in 566 participants receiving hydromethylthi
by University of AberdeenRelationship between steady-state plasma levels of hydromethylthionine and decline on the ADAS-Cog11scale over 65 weeks in 566 participants receiving hydromethylthi
by Marcus Neitzert,German Center for Neurodegenerative DiseasesGroup comparisons, correlation analyses, and diagnostic performance of serum beta-synuclein and plasma pTau181. (A) Serum beta-synu
by Marcus Neitzert,German Center for Neurodegenerative DiseasesGroup comparisons, correlation analyses, and diagnostic performance of serum beta-synuclein and plasma pTau181. (A) Serum beta-synu
by American Heart AssociationCredit: CC0 Public DomainThe makeup of bacteria and other microbes in the gut may have a direct association with dementia risk, according to preliminary research to b
by American Heart AssociationCredit: CC0 Public DomainThe makeup of bacteria and other microbes in the gut may have a direct association with dementia risk, according to preliminary research to b
byUniversity of SurreyGraphical Abstract. Credit:SLEEP(2024). DOI: 10.1093/sleep/zsae193Brain waves can be manipulated while in rapid eye movement (REM) sleep, a sleep stage associat
byUniversity of SurreyGraphical Abstract. Credit:SLEEP(2024). DOI: 10.1093/sleep/zsae193Brain waves can be manipulated while in rapid eye movement (REM) sleep, a sleep stage associat
by University of Miami Leonard M. Miller School of MedicineThe difference in APOE expression between African and European local ancestry carriers. University of Miami Leonard M. Miller School of
by University of Miami Leonard M. Miller School of MedicineThe difference in APOE expression between African and European local ancestry carriers. University of Miami Leonard M. Miller School of
by Uppsala UniversityDespite his team’s successes, Lars Lannfelt does not want to speculate on when an approved treatment can be available for health care. Credit: Johan WahlgrenIn late July ther
by Uppsala UniversityDespite his team’s successes, Lars Lannfelt does not want to speculate on when an approved treatment can be available for health care. Credit: Johan WahlgrenIn late July ther
by Allison Mills,Michigan Technological UniversityCellular toxicity, which is higher in amyloid amorphous aggregates, shows that small changes in protein folding chemistry can cause differences
by Allison Mills,Michigan Technological UniversityCellular toxicity, which is higher in amyloid amorphous aggregates, shows that small changes in protein folding chemistry can cause differences
by IOS PressMental health and activity participation by dementia status per year of assessment. A) Proportion of depressive symptoms. B) Proportion of anxiety. C) Mean score of social activity. D
by IOS PressMental health and activity participation by dementia status per year of assessment. A) Proportion of depressive symptoms. B) Proportion of anxiety. C) Mean score of social activity. D
byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainThe viral ALS Ice Bucket Challenge a few years ago raised major funding that resulted in the discovery of new genes connected to the dis
byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainThe viral ALS Ice Bucket Challenge a few years ago raised major funding that resulted in the discovery of new genes connected to the dis
by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainIn people with no thinking and memory problems, a simple test may predict the risk of developing cognitive impairment years later,
by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainIn people with no thinking and memory problems, a simple test may predict the risk of developing cognitive impairment years later,
by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement